The medical guidance now emphasizes annual flu vaccination for everyone six months and older, updated COVID vaccines for healthy adults, children, and pregnant women, and RSV vaccines for older adults, pregnant people, and infants under eight months.

Three enhanced flu vaccines are available to better protect seniors, and a new mRNA-based flu option (mFlusiva) is approved for adults 50 and up, with some doses arriving soon.

Vaccine timing focuses on an October rollout for flu vaccines, with a coordinated schedule for COVID-19 shots in anticipation of waning immunity and to align with events.

AMA president-elect stressed that an independent online review provides clear, science-based guidance as federal decision-making evolves.

The Vaccine Integrity Project has reviewed hundreds of peer‑reviewed studies since August 2025, continuing a 2025–26 evidence effort and noting disruptions to ACIP processes, with no full restoration yet despite court challenges.

The CDC’s traditional guideline process is stalled due to a lawsuit over vaccine policy changes from the previous administration, fueling confusion and a lack of federal direction.

AMA and Vaccine Integrity Project collaborated with medical societies and public health groups to frame policy questions, appraise emerging evidence, and communicate findings to clinicians and patients.

The overarching goal is clear, consistent, science-based guidance for the public amid evolving federal recommendations and legal disputes surrounding vaccine policy.

There is a push for transparent, science-based information on vaccine safety and effectiveness through public postings by medical groups to offer steady guidance while federal processes are unsettled.

The recommendations aim to be trusted and accessible, addressing uncertainties in federal policy and schedule changes for clinicians and patients alike.

Critics say the season lacks a CDC-led vaccination push, underscoring the need for access to high-quality evidence and physician guidance for informed decisions.

An executive director reaffirmed immunization as a strong tool to prevent severe illness, aligning with evidence of reduced hospitalization and death risk.